Company Overview

Update
Closed:
Closed, Date Unknown
Headquarters:
Seattle, WA
Funding:
$3.1M
Categories:
Biotechnology
Description:
Oncofactor Corporation develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

Detailed Description

Update

Oncofactor Corporation is a Seattle, WA-based developer of cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

Board Members and Advisors (1)

Update

Investors (6)

Update
  • 920ef1c9e2d2a1b871893ee51107f97c

    ARCH Venture Partners

    ARCH invests primarily in companies co-founded with leading scientists and entrepreneurs,...
  • 6b3d691b0a255c3c3665e0bfe13e54e7

    Amgen

    Amgen engages in the development of human therapeutic products in supportive of cancer care,...
  • Ulx1rvk1kpm3akjuyefs

    Alexandria Real Estate Equities

    Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry, is the...
  • 5942af8b16380c2e94b8f90ee255c684

    OVP Venture Partners

    OVP Venture Partners is a venture capital firm specializing in early-stage technology-based...
  • Cg4zzsjswhaydlvfxurs

    WRF Capital

    The Seattle-based Washington Research Foundation supports groundbreaking technology in the life...
  • Df5ef5a37901eb1047c9573bbc345d3c

    Accelerator Corp.

    Accelerator Corporation, founded in 2003

Offices/Locations (1)

Update
  • Office

    Seattle, WA

    USA